EDGAR Filing Documents for 0001600132-17-000113

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001600132-17-000113

Filing Date

2017-10-03

Accepted

2017-10-03 16:07:16

Documents

Period of Report

2017-09-29

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wf-form4_150706122333359.html	4
1	FORM 4	wf-form4_150706122333359.xml	4	5344
	Complete submission text file	0001600132-17-000113.txt		6795

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827

Business Address

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 171117857